London, United Kingdom

Peter Nadudvari

This inventor holds 1 USPTO granted patent. Top assignee: Iqvia Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Nadudvari: Innovator in Clinical Trial Management

Introduction

Peter Nadudvari is a notable inventor based in London, GB. He has made significant contributions to the field of clinical trial management through his innovative solutions. His work focuses on enhancing the efficiency and effectiveness of clinical trials, which are crucial for the advancement of medical research.

Latest Patents

Peter holds a patent for a "Single sign-on clinical trial management platform." This method involves ingesting data from multiple clinical trial site systems associated with various clinical trials. It allows users to access the clinical trial management platform after authenticating their credentials. The platform identifies the specific clinical trial associated with the user and provides access to multiple clinical trial software services. Additionally, it presents a user-specific task list related to the particular clinical trial and establishes a communication link for real-time messaging between users.

Career Highlights

Peter is currently employed at Iqvia Inc., where he continues to develop innovative solutions for clinical trial management. His work is instrumental in streamlining processes and improving communication among clinical trial participants.

Collaborations

Peter collaborates with talented professionals in his field, including Aruna Thapa Adhikari and Gregory Paul Friedman. Their combined expertise contributes to the success of their projects and the advancement of clinical trial management technologies.

Conclusion

Peter Nadudvari's contributions to clinical trial management through his innovative patent demonstrate his commitment to improving medical research processes. His work continues to impact the field positively, paving the way for more efficient clinical trials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…